Summit Therapeutics Stock Forecast

Stock Price Forecast

According to 10 professional analysts, the 12-month price target for Summit Therapeutics stock ranges from a low of $30 to a high of $44. The average analyst price target of $37 forecasts a 60.24% increase in the stock price over the next year.

Price Target: $37.00 (+60.24%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$30	$37	$40	$44
Change	+29.93%	+60.24%	+73.24%	+90.56%

Analyst Ratings

The average analyst rating for Summit Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25	May '25
Strong Buy	3	4	5	6	7	7
Buy	2	2	2	4	4	4
Hold	1	1	1	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	7	8	10	11	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Salveen Richter Goldman Sachs	Goldman Sachs	Strong Buy Maintains $37 → $41	Strong Buy	Maintains	$37 → $41	+77.57%	May 2, 2025
Reni Benjamin JMP Securities	JMP Securities	Buy Reiterates $40	Buy	Reiterates	$40	+73.24%	Apr 28, 2025
Kelly Shi Jefferies	Jefferies	Strong Buy Maintains $31 → $44	Strong Buy	Maintains	$31 → $44	+90.56%	Apr 25, 2025
Eric Schmidt Cantor Fitzgerald	Cantor Fitzgerald	Buy Reiterates n/a	Buy	Reiterates	n/a	n/a	Apr 23, 2025
Yigal Nochomovitz Citigroup	Citigroup	Hold → Strong Buy Upgrades $23 → $35	Hold → Strong Buy	Upgrades	$23 → $35	+51.58%	Mar 26, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

53.05M

EPS This Year

-0.42

from -0.31

EPS Next Year

-0.58

from -0.42

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	860.00K	1.81M	705.00K	-	-	-	53.05M	136.58M
Revenue Growth	6.10%	110.35%	-61.03%	-	-	-	-	157.44%
EPS	-0.76	-0.96	-0.41	-0.99	-0.31	-0.42	-0.58	-0.58
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	11	10	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	174.1M	449.4M
Avg	n/a	53.1M	136.6M
Low	n/a	n/a	9.8M

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	747.1%
Avg	-	-	157.4%
Low	-	-	-81.5%

EPS Forecast

EPS	2025	2026	2027
High	-0.41	-0.47	-0.29
Avg	-0.42	-0.58	-0.58
Low	-0.46	-0.70	-0.86

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.